Skip to main content
Clinical Trials/NCT01144559
NCT01144559
Completed
Phase 4

Continuous Femoral Nerve Blocks: Relative Effects of Basal Infusion and Bolus Doses on Sensory and Motor Function

University of California, San Diego1 site in 1 country15 target enrollmentJune 2010
ConditionsNerve Block

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Nerve Block
Sponsor
University of California, San Diego
Enrollment
15
Locations
1
Primary Endpoint
Quadriceps Femoris Muscle Strength
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

This is a research study to determine if the way local anesthetic- or numbing medication- is delivered through a tiny tube next to the nerves that go to the thigh affects the strength and sensation in the thigh.

Detailed Description

Specific Aim: Research study to test the null hypothesis that differing the delivery method (continuous basal infusion vs. repeated bolus doses) but providing an equal total dose of Ropivacaine has no impact on quadriceps muscle strength. These results will help define the optimal delivery method of local anesthetic used for continuous peripheral nerve blocks and help guide future research in this clinically relevant area.

Registry
clinicaltrials.gov
Start Date
June 2010
End Date
September 2010
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • willing to have bilateral femoral perineural catheters place with a subsequent ropivacaine infusion and motor/sensory testing for 9 hours
  • willing to stay overnight in the UCSD GCRC/CTRI to allow dissipation of local anesthetic infusion effects by the following morning.

Exclusion Criteria

  • current daily analgesic use
  • opioid use with in the previous 4 weeks
  • any neuro-muscular deficit of either femoral nerves and/or quadriceps muscles
  • pregnancy
  • incarceration

Outcomes

Primary Outcomes

Quadriceps Femoris Muscle Strength

Time Frame: Hour 22

The primary end point will be the quadriceps femoris maximum voluntary isometric contraction (MVIC) expressed as percentage of the pre-ropivacaine MVIC: post/pre x 100; with the two sides of each subject compared with each other.

Secondary Outcomes

  • Muscle Strength(Hour 22)
  • Sensory Level(Hour 22)

Study Sites (1)

Loading locations...

Similar Trials